Neurology Advisor
NeurologyAdvisor.com provides healthcare professionals in the field of neurology with a rich source of practical information and resources to help them make informed choices for their patients. Key features include: - Brief summaries of medications - Daily news updates - In-depth feature articles - Exclusive case studies in neurology - Coverage of conferences - Useful clinical charts - Opportunities for continuing medical education (CME) - And much more...
Outlet metrics
Global
#836866
United States
#350254
Health/Health Conditions and Concerns
#997
Articles
-
2 weeks ago |
neurologyadvisor.com | Hibah Khaja
Patients with migraine who identify as evening chronotypes experience greater headache-related disability and worse overall physical and mental health than their morning-type counterparts, according to study results published in the Journal of Sleep Research. Chronotype, an individual’s natural tendency to feel more alert in the morning or evening, has previously been associated with mental health vulnerabilities.
-
2 weeks ago |
neurologyadvisor.com | Ron Goldberg
Significant risk for stroke is found in patients with atrial fibrillation (AF) hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), according to study results presented at Heart Rhythm 2025, held from April 24 to 27, 2025, in San Diego, California. Investigators evaluated the possible association between AF in patients hospitalized for AECOPD with subsequent cerebrovascular accidents (CVAs).
-
2 weeks ago |
neurologyadvisor.com | Jessica Nye
Nearly half of patients with Parkinson disease (PD) who experience anxiety symptoms report anxiety-related activity limitations, which is associated with an increased likelihood of seeking treatment. These are the findings of a study presented at the 2025 American Academy of Neurology (AAN) annual meeting, held from April 5 to 9, 2025, in San Diego, California, and published in the journal Neurology.
-
2 weeks ago |
neurologyadvisor.com | Jessica Nye
Use of cardioprotective glucose-lowering therapies does not affect all-cause dementia risk, according to results of a study published in JAMA Neurology. Observational data suggest that sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) drug classes may have neuroprotective effects.
-
2 weeks ago |
neurologyadvisor.com | Hibah Khaja
Older adults who frequently experience insomnia symptoms or take sleep medications are at greater risk of developing disability over time, according to the findings of a study published in Sleep. For the study, researchers used data from the National Health and Aging Trends Study between 2011 and 2015, analyzing 6722 community-dwelling adults aged 65 years and older.
Neurology Advisor journalists
Contact details
Address
123 Example Street
City, Country 12345
Email Patterns
Website
http://neurologyadvisor.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →